Tirzepatide 22mg/1ml vial

Tirzepatide 22 mg/mL — 1 mL Vial

Total medication in vial: 22 mg tirzepatide

This 1 mL vial contains compounded tirzepatide at a concentration of 22 mg per mL. This higher-concentration option may be appropriate for patients whose individualized treatment plan requires a higher prescribed dose or different injection volume.

Your Phoenix Clinical Services provider will determine the appropriate dose, concentration, and treatment schedule based on your progress, response to treatment, and medication tolerance.

Prescription and medical evaluation required. Do not determine your injection amount based on vial size or concentration alone. Follow only the dosing instructions provided specifically for your prescription. Compounded medications are not FDA-approved and may differ from FDA-approved tirzepatide products.